Harrow Health, Inc.
General ticker "HROW" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $1.2B (TTM average)
Harrow Health, Inc. follows the US Stock Market performance with the rate: 61.1%.
Estimated limits based on current volatility of 2.2%: low 39.36$, high 41.09$
Factors to consider:
- Total employees count: 315 (+45.2%) as of 2023
- Top business risk factors: Profitability concerns, Cybersecurity threats, Regulatory and compliance, Third-party risks, Economic downturns and volatility
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [33.72$, 61.81$]
- 2026-12-31 to 2027-12-31 estimated range: [27.98$, 53.28$]
Financial Metrics affecting the HROW estimates:
- Negative: with PPE of 107.5 at the end of fiscal year the price was high
- Positive: 7.68 < Operating profit margin, % of 13.37
- Positive: 0.07 < Operating cash flow per share per price, % of 2.47
- Negative: Shareholder equity ratio, % of 13.13 <= 19.49
- Positive: Inventory ratio change, % of -0.60 <= 0
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: Interest expense per share per price, % of 1.36 <= 3.29
Short-term HROW quotes
Long-term HROW plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $130.19MM | $199.61MM | $272.30MM |
| Operating Expenses | $129.76MM | $190.79MM | $235.90MM |
| Operating Income | $0.43MM | $8.82MM | $36.40MM |
| Non-Operating Income | $-24.14MM | $-26.14MM | $-40.33MM |
| Interest Expense | $21.32MM | $22.79MM | $24.18MM |
| R&D Expense | $6.65MM | $12.23MM | $15.05MM |
| Income(Loss) | $-23.71MM | $-17.32MM | $-3.93MM |
| Taxes | $0.70MM | $0.16MM | $1.21MM |
| Profit(Loss)* | $-24.41MM | $-17.48MM | $-5.14MM |
| Stockholders Equity | $70.77MM | $69.65MM | $52.45MM |
| Inventory | $10.87MM | $10.70MM | $13.52MM |
| Assets | $312.16MM | $388.97MM | $399.48MM |
| Operating Cash Flow | $3.84MM | $-22.20MM | $43.86MM |
| Capital expenditure | $152.55MM | $38.67MM | $0.89MM |
| Investing Cash Flow | $-152.55MM | $-33.16MM | $-5.46MM |
| Financing Cash Flow | $126.53MM | $28.53MM | $-12.72MM |
| Earnings Per Share** | $-0.75 | $-0.49 | $-0.14 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.